Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
This Week in The Journal

This Week in The Journal

Journal of Neuroscience 9 December 2009, 29 (49) i
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Embedded Image Cellular/Molecular

Activation Voltage of Cav1.3 Underlies Pacemaker Activity

Ilva Putzier, Paul H. M. Kullmann, John P. Horn, and Edwin S. Levitan

(see pages 15414–15419)

Cav1.3 L-type voltage-sensitive calcium channels are expressed in dopaminergic neurons in the substantia nigra, where they activate at subthreshold membrane potentials and drive slow oscillating potentials that underlie pacemaker activity and tonic dopamine release. This effect has been proposed to require fluctuations in calcium concentration and activation of calcium-sensitive potassium channels. But Putzier et al. demonstrate that calcium influx through these channels is not necessary to produce pacemaker activity. Inhibiting Cav1.3 channels eliminated pacemaker activity in midbrain slices from rats, but the activity was restored by simulating the current produced by the channels with the dynamic clamp, which does not involve calcium flux. By taking advantage of the ability to alter various electrical properties of the virtual current independently and comparing the pacemaking ability of altered conductances to those of virtual leak channels and NMDA receptors, the authors determined that the half-maximal activation voltage (V1/2) of Cav1.3 is the critical feature that enables them to support pacemaker activity.

Embedded Image Development/Plasticity/Repair

cAMP Activates Distinct Pathways in Embryonic and Neonatal Neurons

Andrew J. Murray, Steven J. Tucker, and Derryck A. Shewan

(see pages 15434–15444)

Developing axons are guided to their targets by attractive and repulsive cues that act on the growth cone. Some cues, including netrin-1, attract growth cones early in development, but later repel them. This switch in responsiveness is associated with decreasing cAMP levels as development proceeds; artificially increasing cAMP levels late in development switches the response from repulsion back to attraction. Murray et al. identified downstream effectors that mediate the effects of different cAMP concentrations: protein kinase A (PKA) and the guanine nucleotide exchange factor Epac. Epac requires higher cAMP levels for activation than PKA and therefore was activated by netrin-1 in neurons from embryonic, but not neonatal rats. Knockdown of Epac in embryonic neurons caused growth cones to turn away from instead of toward netrin-1, but had no effect on postnatal neurons. In contrast, knockdown of PKA did not alter growth cone responses in embryonic neurons, but switched repulsion to attraction in postnatal neurons.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Fluorescence resonance energy transfer reveals that netrin-1 (right panels) increases (indicated by darker color) activity of Epac in embryonic neurons (top) and of PKA in neonatal neurons (bottom). See the article by Murray et al. for details.

Embedded Image Behavioral/Systems/Cognitive

Monkeys Weight Information by Reliability

Christopher R. Fetsch, Amanda H. Turner, Gregory C. DeAngelis, and Dora E. Angelaki

(see pages 15601–15612)

When integrating information from multiple sources to assess a situation, the optimal strategy is to weight information from each source according to its reliability. It has been hypothesized that animals use this strategy when integrating information from multiple sensory modalities. This has been demonstrated for humans in self-motion detection experiments in which the relative reliability of visual and vestibular information is systematically varied. In such cases, people update their estimates of each modality's reliability on each trial and judge heading direction using the updated values. Experiments by Fetsch et al. suggest that monkeys use a similar strategy. Vestibular stimulation was produced by moving the monkey, while visual stimuli simulated movement through clouds of dots. The reliability of visual stimuli was manipulated by varying the coherence of dot movement. The monkeys' report of perceived self-motion showed that they continually updated their weighting of visual and vestibular information, although the vestibular information was given more weight than predicted.

Embedded Image Neurobiology of Disease

BDNF Regulates SORLA Expression

Michael Rohe, Michael Synowitz, Rainer Glass, Steven M. Paul, Anders Nykjaer, et al.

(see pages 15472–15478)

Sorting-protein-related receptor with A-type repeats (SORLA) regulates trafficking of vesicles containing amyloid precursor protein (APP) between the trans-Golgi network and early endosomes. When SORLA levels are low—which occurs in sporadic cases of Alzheimer's disease—more APP is transported to intracellular compartments containing β-secretase, which cleaves APP to form the toxic amyloid-β species, Aβ40. Rohe et al. have found that SORLA expression levels are regulated by brain-derived neurotrophic factor (BDNF). BDNF-deficient mice had lower SORLA expression compared to wild-type. Bath application of BDNF increased levels of SORLA and decreased levels of Aβ40 in cultured neurons from wild-type mice, but did not reduce Aβ40 in SORLA-null mice. Similarly, BDNF reduced Aβ40 in vivo in wild-type mice but not in SORLA-deficient mice. Because BDNF has been shown to increase APP levels, the authors suggest that simultaneous upregulation of SORLA serves to sequester excess APP in the trans-Golgi network, preventing it from entering the toxic amyloidogenic pathway.

Back to top

In this issue

The Journal of Neuroscience: 29 (49)
Journal of Neuroscience
Vol. 29, Issue 49
9 Dec 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
This Week in The Journal
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
This Week in The Journal
Journal of Neuroscience 9 December 2009, 29 (49) i

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
This Week in The Journal
Journal of Neuroscience 9 December 2009, 29 (49) i
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Cellular/Molecular
    • Development/Plasticity/Repair
    • Behavioral/Systems/Cognitive
    • Neurobiology of Disease
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • This Week in The Journal
  • This Week in The Journal
  • This Week in The Journal
Show more This Week in The Journal
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.